Report Overview
The Global Pharma Hub and Patient Access Support Service Market size is expected to be worth around US$ 10.0 Billion by 2035 from US$ 3.6 Billion in 2025, growing at a CAGR of 10.8% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 45.6% share with a revenue of US$ 1.7 Billion.
Pharma Hub and Patient Access Support Services are becoming essential components of the modern healthcare ecosystem, helping patients, healthcare providers, pharmaceutical manufacturers, and specialty pharmacies navigate complex treatment pathways. These services streamline processes such as program enrollment, insurance verification, prior authorization, reimbursement assistance, financial support, and patient education, ensuring faster and more efficient access to prescribed therapies.
As specialty medications continue to grow in demand, pharmaceutical companies are investing in integrated hub solutions that improve coordination between stakeholders while reducing administrative burdens. Digital technologies, automation, and data-driven platforms are enabling real-time communication, accelerating benefit investigations, and simplifying medication access for patients with chronic and rare diseases.
Patient access support programs also play a critical role in improving treatment adherence by offering personalized guidance, affordability assistance, and ongoing care coordination throughout the therapy journey. Healthcare providers benefit from reduced paperwork and streamlined workflows, allowing them to focus more on patient care.
Growing emphasis on patient-centric healthcare, expanding specialty drug pipelines, and increasing adoption of digital health solutions are expected to drive the demand for pharma hub services worldwide. By connecting manufacturers, providers, pharmacies, and patients through a centralized support system, Pharma Hub and Patient Access Support Services are transforming healthcare delivery, improving treatment outcomes, and enhancing the overall patient experience.
Click here for more information: https://market.us/report/pharma-hub-and-patient-access-support-service-market/
Key Takeaways
The market was valued at US$ 3.6 billion in 2025 and is projected to reach US$ 10.0 billion by 2035, expanding at a CAGR of 10.8% during the forecast period.
By service type, program enrollment emerged as the leading segment, accounting for 33.2% of the overall market share, followed by treatment navigators, reimbursement & affordability services, clinical educators, and specialty pharmacy coordination.
Based on end users, healthcare providers (HCPs) & staff dominated the market with a 52.1% revenue share, reflecting their significant role in patient support service delivery.
North America held the largest regional position, capturing 45.6% of the global market share in 2025.
Key Market Segments
By Service Type
Program Enrollment
Order/Application processing
Ease of enrollment (phone/portal/app)
Program data.
Treatment Navigators
Process flows
Care team training
Systems testing
Reimbursement & Affordability Services
Clinical Educator
Coordination of Specialty Pharmacy/Dispensing
Others
By End Users
Healthcare Providers (HCPs) & Staff
Pharmaceutical Manufacturers
Specialty Pharmacies (SPs)
Others
Top Key Players
Valeris (Formerly PharmaCord)
Fortrea
AssistRx
CareMetx, LLC
ConnectiveRx
Lash Group
McKesson Corporation
NS Pharma, Inc.
Cardinal Health
EVERSANA
United BioSource LLC
Mercalis
Emerging Trends in Pharma Hub and Patient Access Support Services
Digital Patient Enrollment and e-Authorization: Pharma companies are increasingly adopting digital hub platforms that automate benefits verification, prior authorization, and patient enrollment. According to CMS, its healthcare programs provide coverage to more than 100 million people, driving the need for faster and more efficient digital patient support solutions.
Growth of Patient Navigation Services: Patient access programs are expanding beyond reimbursement support to include education, financial guidance, and care coordination. A 2024 U.S. HHS report reviewed patient navigation programs published between 2013 and 2023, highlighting their growing role in improving healthcare access and treatment continuity.
Integration of Specialty Pharmacy and Hub Services: Modern pharma hubs are connecting manufacturers, healthcare providers, specialty pharmacies, and patients through a single platform. These integrated services simplify benefits investigation, prior authorization, and medication access while reducing administrative burden and improving the patient experience.
Increased Focus on Post-Marketing Patient Safety: Pharma hub services are increasingly linked with patient safety monitoring and adverse event reporting. The FDA continuously monitors drugs after approval because medicines are often used by thousands or even millions of patients, making real-world safety tracking an essential industry trend.
Data-Driven Patient Support Programs: Healthcare organizations are using analytics and centralized data platforms to improve patient access and treatment management. CMS provides healthcare coverage for over 100 million beneficiaries**, creating significant demand for data-driven support services that streamline reimbursement and patient engagement.
Major Use Cases of Pharma Hub and Patient Access Support Services
Program Enrollment and Benefits Verification: Pharma hubs simplify patient enrollment by verifying insurance benefits and collecting required documentation before therapy begins. This reduces administrative delays and helps healthcare providers process patient access requests more efficiently across public and private insurance programs.
Prior Authorization and Reimbursement Support: Patient access services assist providers with prior authorization requests, appeals, and reimbursement coordination. Integrated hub programs help accelerate therapy initiation while minimizing paperwork, improving access to specialty medications for patients with complex treatment needs.
Financial Assistance and Affordability Services: Hub services connect eligible patients with copay assistance, manufacturer support programs, and affordability resources. These services reduce financial barriers, helping patients start and continue prescribed therapies while improving medication adherence and treatment outcomes.
Patient Education and Treatment Navigation: Dedicated patient navigators provide education, appointment coordination, and ongoing support throughout the treatment journey. The U.S. HHS identifies patient navigation as an important approach for helping individuals understand healthcare services and improve care coordination.
Adverse Event Reporting and Compliance Management: Pharma hub providers collect treatment information and facilitate adverse event reporting to support regulatory compliance. The FDA maintains post-market safety programs to monitor approved medicines used by millions of patients, making hub-based safety reporting a critical healthcare function.
Conclusion: The Pharma Hub and Patient Access Support Service market is expected to witness significant growth, reaching US$ 10.0 billion by 2035 from US$ 3.6 billion in 2025, at a CAGR of 10.8%. Increasing demand for specialty medications, digital patient support, and efficient reimbursement solutions is driving market expansion. Program enrollment continues to lead the service segment, while healthcare providers remain the primary end users. Advancements in digital platforms, patient navigation, and specialty pharmacy coordination are improving therapy access and treatment adherence. With North America holding the largest market share, the industry is set to play a crucial role in enhancing patient experiences and healthcare efficiency.
Top comments (0)